ABEO icon

Abeona Therapeutics
ABEO

Overview Fund Activity

54 hedge funds and large institutions have $10.5M invested in Abeona Therapeutics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
8
Reduced
16
Closed
8
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$6K

Top Buyers

1
ACM
1
AIGH Capital Management
Maryland
$1.58M
2
IA
2
IFP Advisors
Florida
$175K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$733K
4
WVP
4
Worth Venture Partners
New Jersey
$392K
5
HF
5
HRT Financial
New York
$31K

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$55K
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$69K
3
BNP Paribas Financial Markets
3
BNP Paribas Financial Markets
France
$38
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$703K
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$2K
Name Holding Trade Value Shares
Change 		Shares
Change %
VF
51
Virtu Financial
New York
– -$84K -10,025 Closed
Acadian Asset Management
52
Acadian Asset Management
Massachusetts
– -$78K -9,467 Closed
Charles Schwab
53
Charles Schwab
California
– -$12K -1,411 Closed
Susquehanna International Group
54
Susquehanna International Group
Pennsylvania
– -$4K -447 Closed
Royal Bank of Canada
55
Royal Bank of Canada
Ontario, Canada
– -$2K -271 Closed
1 2
3